Browse Case Studies by
Case Studies in
- Corporate Governance
- Corporate Social Responsibility
- Economics
- Entrepreneurship
- Finance, Accounting & Control
- Leadership
- Marketing
- Organisational Behaviour / HRM
- Social Entrepreneurship
- Strategy
- All Case Studies »
Concept wise Case Studies
- Mergers, Acquisitions and Alliances - Vol. I
- Mergers, Acquisitions and Alliances - Vol. II
- Mergers, Acquisitions and Alliances - Vol. III
- Mergers, Acquisitions and Alliances - Vol. IV
- Airline Industry
- » All Concept wise Cases
Industry wise Case Studies
- Banking and Financing Services
- Retailing
- Energy and Utilities
- Oil and Gas Refining, Marketing and Distribution
- Commercial Aircraft Manufacturing
- » All Industry wise Cases
Region wise Case Studies
Mergers, Acquisitions, Alliances and Synergies Case Study
Case Title:
GlaxoSmithKline (GSK): Post Merger Growth Strategies
Publication Year : 2004
Authors: Blesy Kirthi, G Srikanth
Industry: Pharmaceutical Industry
Region: UK
Case Code: MAA0020
Teaching Note: Not Available
Structured Assignment: Not Available
OR
Abstract:
GlaxoSmithKline (GSK) is one of the largest pharmaceutical companies in the world. It operates in two segments – pharmaceuticals and consumer healthcare. Since the merger of Glaxo Wellcome and SmithKline Beecham in 2000, the company has been reporting increasing financial returns. On one hand, the company is entering into collaborations, agreements and partnerships, restructuring its R&D (Research and Development) and expanding its product portfolio. On the other hand the company is facing stiff competition from its rivals and generic firms.
Pedagogical Objectives:
- To discuss GlaxoSmithKline's financial performance post-merger and the performance of its core products
- To discuss the initiatives taken for growth
- To discuss the future challenges and strategies ahead.
Keywords : Mergers, Acquisitions, Alliances Case Study;GlaxoSmithKline Incorporated; Glaxo Wellcome and SmithKline Beecham; American pharmaceutical industry; Consumer healthcare; Jean-Pierre Garnier; Product pipeline; Nutritional healthcare products; Centres of Excellence for Drug Discovery (CEDD); Therapeutic areas; Generic competition; Over the counter products; Wellbutrin; Growth strategy; Patented products; US Food and Drug Administration
